Inclusion of information about therapeutic alternatives in IRA prescription drug negotiations Brookings

Inclusion of information about therapeutic alternatives in IRA prescription drug negotiations  Brookings

The Inflation Reduction Act (IRA) requires the Secretary of Health and Human Services to consider information on therapeutic alternatives to drugs selected for negotiation. The Secretary must have the necessary …

Read more

President Arrington, Health Task Force Chairman Burgess’s lead letter to CBC on IRA drug development analysis | US House Budget Committee – House Budget Committee

President Arrington, Health Task Force Chairman Burgess's lead letter to CBC on IRA drug development analysis |  US House Budget Committee - House Budget Committee

November 20, 2023 WASHINGTON, USA – House Budget Committee Chairman Jody Arrington (R-TX) and Budget Committee Health Care Task Force Chairman Michael C. Burgess, MD (R-TX) sent a letter to …

Read more